PharmaHub · Pharma Value Chain · Europe

Europe Pharmaceutical Packaging Materials Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The European pharmaceutical packaging materials market encompasses the supply of primary and secondary packaging materials, including glass, plastics, aluminum, and paperboard, used to contain and protect pharmaceutical products across the region. Valued at approximately $34.0 billion in 2025, the market is projected to expand at a compound annual growth rate of 6.2%, driven by rising pharmaceutical demand, aging demographics, and tightening regulatory requirements across the European Union and broader European region.

Market size · 2025
$34 billion
CAGR · 2025–2030
6.2%
Forecast · 2030
$45.9 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $34bn2030 est: $45.9bn
Read the full Europe Pharmaceutical Packaging Materials Market report →

Market Overview

The market encompasses materials for primary packaging, such as glass vials and ampoules, plastic bottles, blister films, prefilled syringes, and closures, as well as secondary packaging components used by pharmaceutical manufacturers across Europe. Western Europe, including Germany, France, and the Benelux countries, represents the largest consumption hub, while Eastern European markets are expanding at higher rates. Growth is supported by the region's position as one of the world's largest pharmaceutical production and consumption centers, home to major multinational drug manufacturers and a robust contract manufacturing ecosystem.

  • Market size of approximately $34.0 billion in 2025 with projected CAGR of 6.2% through the early 2030s
  • Strong regulatory framework including EU Falsified Medicines Directive driving packaging innovation requirements
  • Home to over 2,000 pharmaceutical manufacturing facilities spanning small molecules and biologics

Growth Drivers

Europe's aging population and rising prevalence of chronic diseases are increasing pharmaceutical consumption, requiring greater packaging volumes across solid dose, injectable, and liquid formulations. The expanding biologics and biosimilars market demands specialized packaging solutions such as prefilled syringes and lyophilization stoppers that preserve drug stability. Additionally, regulatory mandates including serialization requirements under the EU Falsified Medicines Directive and sustainability targets under the European Green Deal are compelling pharmaceutical companies to upgrade packaging systems.

  • Growing biologics sector driving demand for high-barrier and specialty primary packaging materials
  • Serialization and track-and-trace compliance requirements under EU regulations creating upgrade cycles
  • Sustainability mandates pushing adoption of recyclable and lightweight packaging materials
Want a deeper cut on Europe Pharmaceutical Packaging Materials Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented across material types, glass (including borosilicate and soda-lime glass for vials and ampoules), plastics (such as cyclic olefin polymers, polyethylene, polypropylene, and PVC for bottles, blisters, and prefilled devices), aluminum (for collapsible tubes and blister foil lidding), and paperboard/paper (for secondary packaging and cartons). Germany represents the largest national market, followed by France, the United Kingdom, and Italy, while Nordic countries demonstrate strong growth in sustainable packaging adoption. Eastern European markets, including Poland and the Czech Republic, are emerging as manufacturing hubs that support regional demand growth.

  • Plastic packaging dominates the market, particularly PVC/PVDC blister packaging and cyclic olefin polymer containers
  • Germany leads European demand, accounting for approximately 20-25% of regional market share
  • Growing regionalization trend as manufacturers seek to reduce supply chain dependencies

Trends and Outlook

What are the recent trends and outlook?

Sustainability is emerging as the dominant strategic theme, with pharmaceutical companies and packaging suppliers investing in recyclable materials, lightweight designs, and reduced carbon footprints to align with European regulatory and corporate sustainability targets. Digitalization of packaging through smart labels, near-field communication tags, and serialization technologies continues to accelerate as manufacturers seek enhanced supply chain traceability and patient engagement capabilities. Looking ahead, the market is expected to maintain robust growth through the early 2030s, supported by pipeline biologics, aging demographics, and ongoing regulatory evolution.

  • Shift toward mono-material and recyclable packaging structures gaining traction amid EU Packaging and Packaging Waste Regulation requirements
  • Growing adoption of connected packaging and digital identifiers supporting compliance and patient safety initiatives
  • Continued investment in regional manufacturing capacity and nearshoring to mitigate supply chain risks
Talk to a Claight analyst
Do you want to research Europe Pharmaceutical Packaging Materials Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.